Rapid and robust evolution of collateral sensitivity in
Journal
Science advances
ISSN: 2375-2548
Titre abrégé: Sci Adv
Pays: United States
ID NLM: 101653440
Informations de publication
Date de publication:
08 2020
08 2020
Historique:
received:
12
12
2019
accepted:
22
06
2020
entrez:
22
8
2020
pubmed:
22
8
2020
medline:
12
4
2022
Statut:
epublish
Résumé
The analysis of trade-offs, as collateral sensitivity, associated with the acquisition of antibiotic resistance, is mainly based on the use of model strains. However, the possibility of exploiting these trade-offs for fighting already resistant isolates has not been addressed in depth, despite the fact that bacterial pathogens are frequently antibiotic-resistant, forming either homogeneous or heterogeneous populations. Using a set of
Identifiants
pubmed: 32821825
doi: 10.1126/sciadv.aba5493
pii: aba5493
pmc: PMC7406369
doi:
Substances chimiques
Anti-Bacterial Agents
0
Ceftazidime
9M416Z9QNR
Tobramycin
VZ8RRZ51VK
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
eaba5493Informations de copyright
Copyright © 2020 The Authors, some rights reserved; exclusive licensee American Association for the Advancement of Science. No claim to original U.S. Government Works. Distributed under a Creative Commons Attribution NonCommercial License 4.0 (CC BY-NC).
Références
Antimicrob Agents Chemother. 2017 Dec 21;62(1):
pubmed: 29084746
Drugs. 2003;63(22):2501-20
pubmed: 14609360
Mol Biol Evol. 2017 Sep 1;34(9):2229-2244
pubmed: 28541480
Front Genet. 2018 Oct 18;9:451
pubmed: 30405685
mBio. 2018 May 15;9(3):
pubmed: 29764951
Proc Biol Sci. 2016 May 11;283(1830):
pubmed: 27170722
Environ Microbiol. 2016 Oct;18(10):3482-3493
pubmed: 27119970
Gene. 1998 May 28;212(1):77-86
pubmed: 9661666
PLoS Biol. 2017 Aug 8;15(8):e2001586
pubmed: 28792497
Antimicrob Agents Chemother. 2013 Nov;57(11):5406-14
pubmed: 23959314
Nat Commun. 2014 Jul 08;5:4352
pubmed: 25000950
PLoS Genet. 2009 Jul;5(7):e1000578
pubmed: 19629166
Nat Commun. 2019 Jan 18;10(1):334
pubmed: 30659188
Environ Microbiol. 2012 Aug;14(8):2200-11
pubmed: 22672046
PLoS Genet. 2011 Mar;7(3):e1001321
pubmed: 21408208
Mol Biol Evol. 2019 Oct 1;36(10):2238-2251
pubmed: 31228244
Antimicrob Agents Chemother. 2018 Sep 24;62(10):
pubmed: 30082283
PLoS One. 2013;8(4):e60225
pubmed: 23573242
Trends Microbiol. 2015 Jul;23(7):401-7
pubmed: 25818802
Antimicrob Agents Chemother. 2016 Jan 04;60(3):1767-78
pubmed: 26729493
Microbiology. 2009 Apr;155(Pt 4):1050-1057
pubmed: 19332807
Science. 2014 Sep 12;345(6202):1299-301
pubmed: 25214620
Proc Natl Acad Sci U S A. 2014 Oct 7;111(40):14494-9
pubmed: 25246554
Science. 2014 Jun 27;344(6191):1519-1522
pubmed: 24970088
Science. 2016 Jan 1;351(6268):aad3292
pubmed: 26722002
Nat Commun. 2018 Sep 10;9(1):3673
pubmed: 30202004
Sci Transl Med. 2013 Sep 25;5(204):204ra132
pubmed: 24068739
Nat Commun. 2016 Oct 03;7:13002
pubmed: 27694971
Am J Respir Crit Care Med. 2014 Aug 1;190(3):289-97
pubmed: 24937177
Sci Transl Med. 2014 Nov 12;6(262):262ra156
pubmed: 25391482
PLoS Pathog. 2010 Jan 22;6(1):e1000735
pubmed: 20107608
J Bacteriol. 1952 Oct;64(4):489-99
pubmed: 12999676
Antimicrob Agents Chemother. 2010 Oct;54(10):4159-67
pubmed: 20679510
Antimicrob Agents Chemother. 2019 Sep 30;:
pubmed: 31570397
Cell. 2018 Jan 11;172(1-2):121-134.e14
pubmed: 29307490
J Evol Biol. 2009 May;22(5):997-1003
pubmed: 19298493
Mol Biol Evol. 2019 Aug 1;36(8):1601-1611
pubmed: 31058961
J Antimicrob Chemother. 2018 Dec 1;73(12):3322-3331
pubmed: 30189050
PLoS Biol. 2018 Apr 30;16(4):e2004356
pubmed: 29708964
Antimicrob Agents Chemother. 2000 Sep;44(9):2242-6
pubmed: 10952562
Elife. 2019 Oct 29;8:
pubmed: 31658946
Mol Syst Biol. 2013 Oct 29;9:700
pubmed: 24169403